Transform IVD Performance with a Hybrid Monitoring Approach Webinar

Effective monitoring is critical to the success of an IVD clinical performance study. But as studies become more complex, choosing the right monitoring model can be a challenge.

On-site monitoring provides valuable visibility, relationship-building and the opportunity to identify issues within the laboratory environment. Remote monitoring can improve efficiency, reduce travel and lessen the burden of frequent site visits. However, neither approach is always sufficient on its own.

That is where a hybrid monitoring model can add real value.

On 1 October 2026, ARC Regulatory’s Dr Ciara Devlin, Research Operations Lead, and Andrew Mercier, Alliance Manager, will join Xtalks for Transform IVD Performance with a Hybrid Monitoring Approach, exploring how a combination of remote and on-site monitoring can support stronger oversight of complex IVD studies.

Why hybrid monitoring?

A hybrid approach combines the flexibility of remote monitoring with the additional visibility and support provided by face-to-face site visits.

For sponsors, this can help to:

• Identify issues earlier, including those that may be difficult to detect remotely
• Strengthen relationships with sites and encourage greater transparency
• Resolve actions more efficiently before they develop into larger study risks
• Maintain visibility of laboratory environments, processes and documentation
• Support inspection readiness and provide greater confidence in study conduct

Monitoring strategies should always be risk-based and tailored to the individual study. For higher-risk or more complex IVD studies, combining remote and on-site activities can provide a stronger balance between efficiency and effective oversight.

Moving beyond theory

The webinar will take a practical look at the strengths and limitations of different monitoring approaches.

Andrew and Ciara will explore real-world scenarios showing how challenges such as incomplete documentation, unresolved actions, access issues and limited site visibility can affect remote monitoring.

They will also examine how consistent monitoring and stronger relationships between CRAs and sites can improve transparency, reduce outstanding actions and help identify wider or systemic issues before they escalate.

The session will also consider the role technology and AI may play in supporting monitoring activities in the future, while recognising the continued importance of human oversight and on-site interaction in complex IVD studies.

Join the webinar

For IVD manufacturers, diagnostic developers and clinical teams looking to strengthen study oversight while managing time, cost and operational demands, the webinar will provide practical insight into developing a more effective monitoring strategy.